This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Chongqing Upgra Biotechnology Co., Ltd.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Qiang Luo: Innovator in Polyethylene Glycol Conjugate Drugs
Introduction
Qiang Luo is a prominent inventor based in Chongqing, China. He has made significant contributions to the field of medicine, particularly in the development of polyethylene glycol conjugate drugs. With a total of 2 patents to his name, Luo's work is paving the way for advancements in pharmaceutical compositions.
Latest Patents
Luo's latest patents include innovative formulations and methods related to polyethylene glycol conjugated drugs. The first patent focuses on a polyethylene glycol conjugate drug, detailing its preparation method and various uses. This invention is particularly relevant in the technical field of medicines, showcasing a novel approach to drug formulation. The second patent also pertains to a polyethylene glycol conjugate medicament, emphasizing its preparation method and applications in creating effective pharmaceutical compositions.
Career Highlights
Qiang Luo is currently associated with Chongqing Upgra Biotechnology Co., Ltd. His work at this company highlights his commitment to advancing medical technology and improving drug delivery systems. His innovative research has the potential to enhance therapeutic outcomes for patients.
Collaborations
Luo collaborates with notable colleagues, including Gaoquan Li and Dajun Li. These partnerships foster a collaborative environment that encourages the exchange of ideas and expertise in the field of biotechnology.
Conclusion
Qiang Luo's contributions to the development of polyethylene glycol conjugate drugs represent a significant advancement in the pharmaceutical industry. His innovative patents and collaborative efforts are set to make a lasting impact on medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile